Krn-5500

KRN5500 is a semisynthetic derivative of the nucleoside-like antineoplastic antibiotic spicamycin, first isolated from the bacterium Streptomyces alanosinicus. KRN 5500 inhibits protein synthesis by interfering with endoplasmic reticulum and Golgi apparatus functions. This agent also induces cell differentiation and caspase-dependent apoptosis. The directory classifies it as a clinical API with a semi-synthetic source/manufacturing origin. Other names for this substance include Benzoylated spicamycin analogue and Krn 5500. Its PubChem CID is 6440176.

CAS No 151276-95-8
Molecular Formula C28H43N7O7
Molecular Weight 589.70 g/mol
Synonyms (2E,4E)-N-[2-[[(2R,3R,4R,5R,6S)-2-[(1S)-1,2-dihydroxyethyl]-4,5-dihydroxy-6-(7H-purin-6-ylamino)oxan-3-yl]amino]-2-oxoethyl]tetradeca-2,4-dienamide

Frequently Asked Questions